Keywords: teva, reports, record, annual, sales, 3b, israel
Teva reports record annual sales of $3.3B
Article | 01 March 2004
Israel's generics giant Teva Pharmaceutical Industries has announced record sales for full-year 2003 of $3.3 billion, rocketing 30% from the previous year. In 2003, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
